The clinical chemistry score (CCS) achieves the highest efficacy when assessed with the 99% sensitivity benchmark for myocardial infarction

Approaches and algorithms used for early decision making for patients with suspected acute coronary syndrome (ACS) should assess sensitivity and specificity, in addition to predictive values [1,2]. Benchmarks for these diagnostic parameters vary; however, a seminal publication from the International Journal of Cardiology indicates “a sensitivity of 99% or higher for AMI or other MACE” [3]. Herein, it is surprising that Yildirim and colleagues did not consider the 99% sensitivity benchmark when assessing the various laboratory approaches/algorithms to rule-out myocardial infarction (MI) [4].
Source: International Journal of Cardiology - Category: Cardiology Authors: Source Type: research